Including all individuals is not enough: Lessons for intention-to-treat analysis

Clinical Trials

Volumn 9, Issue 4, 2012, Pages 396-407

  White, Ian R ^a   Carpenter, James ^b   Horton, Nicholas J ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c SMITH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CLINICAL OBSERVATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; MENTAL DISEASE; MENTAL HEALTH; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; SENSITIVITY ANALYSIS; TREATMENT WITHDRAWAL;

DATA INTERPRETATION, STATISTICAL; HUMANS; INTENTION TO TREAT ANALYSIS; LIKELIHOOD FUNCTIONS; LOST TO FOLLOW-UP; MODELS, STATISTICAL; PATIENT DROPOUTS; SAMPLE SIZE; SELECTION BIAS; TREATMENT OUTCOME;

EID: 84865490979     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774512450098     Document Type: Article

References (64)

1. Newell DJ. Intention-to-treat analysis: Implications for quantitative and qualitative research. Int J Epidemiol. 1992 ; 21: 837-41
2. McKnight P, McKnight KM, Sidani S, Figueredo AJ Missing Data: A Gentle Introduction. New York: The Guilford Press ; 2007 :
3. Missing data: Discussion points from the PSI missing data expert group. Pharm Stat. 2010 ; 9: 288-97
4. The Prevention and Treatment of Missing Data in Clinical Trials. Washington, DC: The National Academies Press ; 2010 :
5. Little RJA, Rubin DB Statistical Analysis with Missing Data. 2 nd edn). Wiley, Hoboken, NJ, 2002. Hoboken, NJ: Wiley ; 2002 :
6. Altman DG, Schulz KF, Moher D. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. et al Ann Intern Med. 2001 ; 134: 663-94
7. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999 ; 319: 670-74
8. Committee for Proprietary Medicinal Products (CPMP). Points to consider on missing data, 2001. Available at: http://www.emea.europa.eu/pdfs/human/ewp/ 177699EN.pdf
9. Altman D. Missing outcomes in randomized trials: Addressing the dilemma. Open Med. 2009 ; 3 (2). e51-53
10. European Medicines Agency. Guideline on missing data in confirmatory clinical trials, 2010. Available at: http://www.ema.europa.eu/ema/pages/ includes/document/open-document.jsp?webContentId=WC500096793
11. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ. 2010 ; 340: c332
12. White IR, Horton N, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ. 2011 ; 342: d40
13. White IR. Uses and limitations of randomization-based efficacy estimators. Stat Methods Med Res. 2005 ; 14: 327-47
14. Center for Drug Evaluation and Research (CDER).Guidance for industry: Antiretroviral drugs using plasma HIV RNA measurements-Clinical considerations for accelerated and traditional approval, 2002. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM070968.pdf (accessed 18 October 2010).
15. Wood A, White IR, Thompson SG. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials. 2004 ; 1: 368-76
16. Kenward MG, Molenberghs G. Last observation carried forward: A crystal ball?. J Biopharm Stat. 2009 ; 19: 872-88
17. Molenberghs G, Thijs H, Jansen I. Analyzing incomplete longitudinal clinical trial data. et al Biostatistics. 2004 ; 5: 445-64
18. Lane P. Handling drop-out in longitudinal clinical trials: A comparison of the LOCF and MMRM approaches. Pharm Stat. 2008 ; 7: 93-106
19. Carpenter J, Kenward M, Evans S, White I. Re: Last observation carry-forward and last observation analysis (Shao J, Zhong B, Stat Med 2003; 22: 2429-41). Stat Med. 2004 ; 23: 3241-42
20. Siddiqui O, Hung HM, O'Neill R. MMRM vs. LOCF: A comprehensive comparison based on simulation study and 25 NDA datasets. J Biopharm Stat. 2009 ; 19: 227-46
21. Heyting A, Tolboom JTBM, Essers JGA. Statistical handling of drop-outs in longitudinal clinical trials. Stat Med. 1992 ; 11: 2043-61
22. Shao J, Zhong B. Last observation carry-forward and last observation analysis. Stat Med. 2003 ; 22: 2429-41
23. Sutton S, Gilbert H. Effectiveness of individually tailored smoking cessation advice letters as an adjunct to telephone counselling and generic self-help materials: Randomized controlled trial. Addiction. 2007 ; 102: 994-1000
24. Linear Mixed Models in Practice. Verbeke G Molenberghs G, ed. New York: Springer-Verlag ; 1997 :
25. Potthoff RF, Tudor GE, Pieper KS, Hasselblad V. Can one assess whether missing data are missing at random in medical studies?. Stat Methods Med Res. 2006 ; 15: 213-34
26. Rubin DB Multiple Imputation for Nonresponse in Surveys. New York: John Wiley and Sons ; 1987 :
27. van Buuren S Flexible Imputation of Missing Data. Boca Raton, FL: CRC Press ; 2012 :
28. Royston P. Multiple imputation of missing values. Stata J. 2004 ; 4: 227-41
29. NovoAASchaferJL. Package NORM. R package version 1.0-9.2, 2010.
30. van BuurenSOudshoornCGM. Multivariate imputation by chained equations: MICE V1.0 user's manual. TNO Report PG/VGZ/00.038. TNO Preventie en Gezondheid, Leiden, 2000. Available at: http://www.multiple-imputation.com/
31. SAS/STAT 9.1 User's Guide (Ch. 46). Cary, NC: SAS Institute Inc. ; 2004 :
32. Stata Multiple-Imputation Reference Manual. College Station, TX: Stata Press ; 2009 :
33. Robins J, Wang N. Inference for imputation estimators. Biometrika. 2000 ; 87 (1). 113-24
34. Meng XL. Multiple-imputation inferences with uncongenial sources of input. Stat Sci. 1994 ; 9: 538-58
35. Royston P, Carlin JB, White IR. Multiple imputation of missing values: New features for mim. Stata J. 2009 ; 9: 252-64
36. CarpenterJRKenwardMG. Missing Data in Clinical Trials-A Practical Guide. Publication RM03/JH17/MK. National Institute for Health Research, Birmingham, 2008. Available at: http://www.pcpoh.bham.ac.uk/publichealth/methodology/ projects/RM03-JH17-MK.shtml
37. White IR, Moodie E, Thompson SG, Croudace T. A modelling strategy for the analysis of clinical trials with partly missing longitudinal data. Int J Methods Psychiatr Res. 2003 ; 12: 139-50
38. Lachin JM. Statistical considerations in the intent-to-treat principle. Control Clin Trials. 2000 ; 21: 167-89
39. Lavori PW. Clinical trials in psychiatry-Should protocol deviation censor patient data?. Neuropsychopharmacology. 1992 ; 6: 39-48
40. Lavori P, Dawson R. Designing for intent-to-treat. Drug Inf J. 2001 ; 35: 1079-86
41. Little R, Yau L. Intent-to-treat analysis for longitudinal studies with dropout. Biometrics. 1996 ; 52: 1324-33
42. Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ. 2009 ; 338: b2393
43. Sabin CA, Lepri AC, Phillips AN. A practical guide to applying the intention-to-treat principle to clinical trials in HIV infection. HIV Clin Trials. 2000 ; 1: 31-38
44. Shih WJ. Problems in dealing with missing data and informative censoring in clinical trials. Curr Control Trials Cardiovasc Med. 2002 ; 3: 4
45. Kenward MG, Goetghebeur EJT, Molenberghs G. Sensitivity analysis for incomplete categorical tables. Stat Model. 2001 ; 1: 31-48
46. White IR, Carpenter J, Evans S, Schroter S. Eliciting and using expert opinions about dropout bias in randomised controlled trials. Clin Trials. 2007 ; 4: 125-39
47. Rotnitzky A, Robins JM, Scharfstein DO. Semiparametric regression for repeated outcomes with nonignorable nonresponse. J Am Stat Assoc. 1998 ; 93: 1321-39
48. Daniels MJ, Hogan JW. Reparameterizing the pattern mixture model for sensitivity analyses under informative dropout. Biometrics. 2000 ; 56: 1241-48
49. Molenberghs G, Kenward MG, Goetghebeur E. Sensitivity analysis for incomplete contingency tables: The Slovenian plebiscite case. J Roy Stat Soc C-App. 2001 ; 50: 15-29
50. Matts JP, Launer CA, Nelson ET, Miller C, Dain B. A graphical assessment of the potential impact of losses to follow-up on the validity of study results. Stat Med. 1997 ; 16: 1943-54
51. Hollis S. A graphical sensitivity analysis for clinical trials with non-ignorable missing binary outcome. Stat Med. 2002 ; 21: 3823-34
52. Rubin DB, Stern HS, Vehovar V. Handling 'don't know' survey responses: The case of the Slovenian plebiscite. J Am Stat Assoc. 1995 ; 90: 822-28
53. Liang KY, Zeger SL. Longitudinal data analysis of continuous and discrete responses for pre-post designs. Sankhya Ser B. 2000 ; 62: 134-48
54. Liu GF, Lu K, Mogg R, Mallick M, Mehrotra DV. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?. Stat Med. 2009 ; 28: 2509-30
55. White IR, Thompson SG. Adjusting for partially missing baseline measurements in randomised trials. Stat Med. 2005 ; 24: 993-1007
56. Kenward M, White IR, Horton N, Carpenter J. Re: Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? (Liu GF et al., Stat Med 2009; 28: 2509-30). Stat Med. 2010 ; 29: 1455-56
57. Riper H, Kramer J, Smit F. Web-based self-help for problem drinkers: A pragmatic randomized trial. et al Addiction. 2008 ; 103: 218-27
58. Burns T, Creed F, Fahy T, et al. Intensive versus standard case management for severe psychotic illness: A randomised trial. UK700 trial group. Lancet. 1999 ; 353: 2185-89
59. Greenland S, Finkle W. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol. 1995 ; 142: 1255-64
60. White IR, Kalaitzaki R, Thompson SG. Allowing for missing outcome data and incomplete uptake of randomised interventions, with application to an Internet-based alcohol trial. Stat Med. 2011 ; 30: 3192-207
61. Royston P. Multiple imputation of missing values: Update. Stata J. 2005 ; 5: 188-201
62. Royston P. Multiple imputation of missing values: Further update of ice, with an emphasis on categorical variables. Stata J. 2009 ; 9: 466-77
63. Wood A, White I, Hillsdon M, Carpenter J. Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes. Int J Epidemiol. 2005 ; 34: 89-99
64. Zeger S, Liang K, Albert P. Models for longitudinal data: A generalized estimating equation approach. Biometrics. 1988 ; 44: 1049-60